DOMESCO Medical Import Export JSC (DMC) - Net Assets
Based on the latest financial reports, DOMESCO Medical Import Export JSC (DMC) has net assets worth ₫1.69 Trillion VND (≈ $64.13 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫1.90 Trillion ≈ $72.28 Million USD) and total liabilities (₫214.61 Billion ≈ $8.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DMC financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫1.69 Trillion |
| % of Total Assets | 88.72% |
| Annual Growth Rate | 5.1% |
| 5-Year Change | 23.56% |
| 10-Year Change | N/A |
| Growth Volatility | 1.04 |
DOMESCO Medical Import Export JSC - Net Assets Trend (2019–2025)
This chart illustrates how DOMESCO Medical Import Export JSC's net assets have evolved over time, based on quarterly financial data. Also explore total assets of DOMESCO Medical Import Export JSC for the complete picture of this company's asset base.
Annual Net Assets for DOMESCO Medical Import Export JSC (2019–2025)
The table below shows the annual net assets of DOMESCO Medical Import Export JSC from 2019 to 2025. For live valuation and market cap data, see DMC market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₫1.69 Trillion ≈ $64.13 Million |
+4.67% |
| 2024-12-31 | ₫1.61 Trillion ≈ $61.27 Million |
+6.05% |
| 2023-12-31 | ₫1.52 Trillion ≈ $57.77 Million |
+4.18% |
| 2022-12-31 | ₫1.46 Trillion ≈ $55.45 Million |
+6.84% |
| 2021-12-31 | ₫1.37 Trillion ≈ $51.90 Million |
+3.85% |
| 2020-12-31 | ₫1.32 Trillion ≈ $49.98 Million |
+5.04% |
| 2019-12-31 | ₫1.25 Trillion ≈ $47.58 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to DOMESCO Medical Import Export JSC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 76.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₫198.03 Billion | 11.73% |
| Other Components | ₫1.49 Trillion | 88.27% |
| Total Equity | ₫1.69 Trillion | 100.00% |
DOMESCO Medical Import Export JSC Competitors by Market Cap
The table below lists competitors of DOMESCO Medical Import Export JSC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
St. James's Place plc
LSE:STJ
|
$76.53 Million |
|
Hektar Real Estate Investment Trust
KLSE:5121
|
$76.57 Million |
|
GAMING INNOVATION DL 1
F:GI11
|
$76.60 Million |
|
Laboratorios Richmond SACIF
BA:RICH
|
$76.61 Million |
|
MHC Plantations Bhd
KLSE:5026
|
$76.49 Million |
|
Altisource Portfolio Solutions SA
NASDAQ:ASPS
|
$76.47 Million |
|
Optex Systems Holdings, Inc. Common Stock
NASDAQ:OPXS
|
$76.45 Million |
|
The State Trading Corporation of India Limited
NSE:STCINDIA
|
$76.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DOMESCO Medical Import Export JSC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,612,567,902,687 to 1,687,875,028,487, a change of 75,307,125,800 (4.7%).
- Net income of 198,031,786,940 contributed positively to equity growth.
- Dividend payments of 86,818,662,500 reduced retained earnings.
- Other factors decreased equity by 35,905,998,640.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₫198.03 Billion | +11.73% |
| Dividends Paid | ₫86.82 Billion | -5.14% |
| Other Changes | ₫-35.91 Billion | -2.13% |
| Total Change | ₫- | 4.67% |
Book Value vs Market Value Analysis
This analysis compares DOMESCO Medical Import Export JSC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.61x to 1.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ₫36059.89 | ₫58000.00 | x |
| 2020-12-31 | ₫37876.99 | ₫58000.00 | x |
| 2021-12-31 | ₫39335.77 | ₫58000.00 | x |
| 2022-12-31 | ₫42027.56 | ₫58000.00 | x |
| 2023-12-31 | ₫43784.17 | ₫58000.00 | x |
| 2024-12-31 | ₫46434.94 | ₫58000.00 | x |
| 2025-12-31 | ₫48603.46 | ₫58000.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DOMESCO Medical Import Export JSC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.73%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.58%
- • Asset Turnover: 1.09x
- • Equity Multiplier: 1.13x
- Recent ROE (11.73%) is below the historical average (13.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 18.58% | 15.84% | 0.96x | 1.22x | ₫107.41 Billion |
| 2020 | 13.65% | 12.37% | 0.99x | 1.11x | ₫48.00 Billion |
| 2021 | 11.66% | 10.63% | 0.92x | 1.19x | ₫22.68 Billion |
| 2022 | 13.71% | 12.56% | 0.87x | 1.26x | ₫54.12 Billion |
| 2023 | 12.06% | 10.66% | 0.93x | 1.22x | ₫31.28 Billion |
| 2024 | 12.57% | 10.67% | 1.03x | 1.14x | ₫41.45 Billion |
| 2025 | 11.73% | 9.58% | 1.09x | 1.13x | ₫29.24 Billion |
Industry Comparison
This section compares DOMESCO Medical Import Export JSC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,859,981,695,433
- Average return on equity (ROE) among peers: 16.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DOMESCO Medical Import Export JSC (DMC) | ₫1.69 Trillion | 18.58% | 0.13x | $76.53 Million |
| Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) | $1.14 Trillion | 16.58% | 0.37x | $179.14 Million |
| DHG Pharmaceutical JSC (DHG) | $3.57 Trillion | 20.74% | 0.25x | $496.76 Million |
| Imexpharm Corp (IMP) | $1.56 Trillion | 10.42% | 0.18x | $297.25 Million |
| Traphaco JSC (TRA) | $1.17 Trillion | 16.70% | 0.41x | $121.26 Million |
About DOMESCO Medical Import Export JSC
Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical products, herbal-origin medicines, functional foods, purified drinking water, and herbal-based beverages in Vietnam. The company engages in the import and export of medicines, pharmaceutical raw materials, food and functional food ingredients, me… Read more